Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Aygestin, Viracept, Dipentum
Link ID 439
Title FDA Safety Changes: Aygestin, Viracept, Dipentum
Url http://www.medscape.com/viewarticle/565162?src=rss
Description The FDA has approved revisions to the safety labeling for norethindrone acetate tablets (Aygestin), nelfinavir mesylate tablets and oral powder (Viracept), and olsalazine sodium capsules (Dipentum). Medscape Medical News
Category Articles > HIV/AIDS
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. Acyclovir for HSV-2 Infection Does Not Prevent HIV
  Long-term treatment of HSV-2 infection with acyclovir does not reduce the rate of new HIV infections, researchers reported at the International AIDS Conference here last week. They said the findings are surprising, because prior HSV-2 infection has been reported to increase the risk of HIV many fold. Reuters Health Information
Category:   Articles > HIV/AIDS


2. Herpes Simplex Suppression Does Not Lower HIV Risk in Tanzanian Women
  Treatment with acyclovir as suppressive therapy for herpes simplex virus-2 (HSV-2) infection does not reduce the risk of HIV infection, according to a study of young women in northwestern Tanzania. Reuters Health Information
Category:   Articles > HIV/AIDS


3. Efavirenz-Based HAART Most Effective First Treatment of Advanced HIV Infection
  Efavirenz (EFV)-based therapy is more effective than lopinavir/ritonavir (LPV/r)-based therapy in antiretroviral-na?ve HIV patients with "very advanced" infections, new research shows. Reuters Health Information
Category:   Articles > HIV/AIDS


4. Some HIV-1 Antibodies Neutralize Diverse HIV-1 Isolates
  Several recent studies showing that antibodies produced by some people infected with HIV-1 can neutralize diverse HIV-1 isolates provide new insights into the viral epitopes targeted by such broadly reactive neutralizing antibodies (NAbs). Reuters Health Information
Category:   Articles > HIV/AIDS


5. Pegylated Liposomal Doxorubicin Prevents Relapse of HIV-Related Kaposi Sarcoma
  Among HIV-infected patients treated with pegylated liposomal doxorubicin for Kaposi sarcoma (KS), relapse rates are low, according to a report in the August 1st issue of Clinical Infectious Diseases. Reuters Health Information
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS